Annual Total Long Term Liabilities
$2.64 B
+$1.22 B+85.83%
31 December 2023
Summary:
DexCom annual total long term liabilities is currently $2.64 billion, with the most recent change of +$1.22 billion (+85.83%) on 31 December 2023. During the last 3 years, it has risen by +$790.00 million (+42.71%). DXCM annual total long term liabilities is now at all-time high.DXCM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$2.64 B
-$2.40 M-0.09%
30 September 2024
Summary:
DexCom quarterly total long term liabilities is currently $2.64 billion, with the most recent change of -$2.40 million (-0.09%) on 30 September 2024. Over the past year, it has dropped by -$9.40 million (-0.35%). DXCM quarterly long term liabilities is now -0.39% below its all-time high of $2.65 billion, reached on 30 June 2023.DXCM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +85.8% | -0.3% |
| 3 y3 years | +42.7% | +38.6% |
| 5 y5 years | +156.2% | +140.3% |
DXCM Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +85.8% | -0.4% | +86.2% |
| 5 y | 5 years | at high | +156.2% | -0.4% | +140.3% |
| alltime | all time | at high | >+9999.0% | -0.4% | >+9999.0% |
DexCom Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.64 B(-0.1%) |
| June 2024 | - | $2.64 B(+0.1%) |
| Mar 2024 | - | $2.64 B(+0.0%) |
| Dec 2023 | $2.64 B(+85.8%) | $2.64 B(-0.4%) |
| Sept 2023 | - | $2.65 B(-0.0%) |
| June 2023 | - | $2.65 B(+86.9%) |
| Mar 2023 | - | $1.42 B(-0.2%) |
| Dec 2022 | $1.42 B(-34.5%) | $1.42 B(-34.7%) |
| Sept 2022 | - | $2.17 B(+0.9%) |
| June 2022 | - | $2.15 B(-0.1%) |
| Mar 2022 | - | $2.16 B(-0.6%) |
| Dec 2021 | $2.17 B(+17.3%) | $2.17 B(+13.9%) |
| Sept 2021 | - | $1.90 B(-0.0%) |
| June 2021 | - | $1.91 B(+1.2%) |
| Mar 2021 | - | $1.88 B(+1.8%) |
| Dec 2020 | $1.85 B(+60.6%) | $1.85 B(+1.2%) |
| Sept 2020 | - | $1.83 B(+3.4%) |
| June 2020 | - | $1.77 B(+51.0%) |
| Mar 2020 | - | $1.17 B(+1.6%) |
| Dec 2019 | $1.15 B(+11.8%) | $1.15 B(+4.8%) |
| Sept 2019 | - | $1.10 B(+0.9%) |
| June 2019 | - | $1.09 B(+1.8%) |
| Mar 2019 | - | $1.07 B(+3.9%) |
| Dec 2018 | $1.03 B(+197.9%) | $1.03 B(+187.6%) |
| Sept 2018 | - | $358.20 M(+1.0%) |
| June 2018 | - | $354.60 M(+1.3%) |
| Mar 2018 | - | $350.00 M(+1.2%) |
| Dec 2017 | $345.80 M(+1983.1%) | $345.80 M(+1.5%) |
| Sept 2017 | - | $340.70 M(+1.2%) |
| June 2017 | - | $336.80 M(+1802.8%) |
| Mar 2017 | - | $17.70 M(+6.6%) |
| Dec 2016 | $16.60 M(+325.6%) | $16.60 M(+18.6%) |
| Sept 2016 | - | $14.00 M(+12.0%) |
| June 2016 | - | $12.50 M(+204.9%) |
| Mar 2016 | - | $4.10 M(+5.1%) |
| Dec 2015 | $3.90 M(+2.6%) | $3.90 M(-15.2%) |
| Sept 2015 | - | $4.60 M(+31.4%) |
| June 2015 | - | $3.50 M(-5.4%) |
| Mar 2015 | - | $3.70 M(-2.6%) |
| Dec 2014 | $3.80 M | $3.80 M(0.0%) |
| Sept 2014 | - | $3.80 M(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $4.50 M(-13.5%) |
| Mar 2014 | - | $5.20 M(-17.5%) |
| Dec 2013 | $6.30 M(-33.7%) | $6.30 M(-21.3%) |
| Sept 2013 | - | $8.00 M(-10.1%) |
| June 2013 | - | $8.90 M(-1.1%) |
| Mar 2013 | - | $9.00 M(-5.3%) |
| Dec 2012 | $9.50 M(+630.8%) | $9.50 M(+344.1%) |
| Sept 2012 | - | $2.14 M(-5.1%) |
| June 2012 | - | $2.25 M(-3.5%) |
| Mar 2012 | - | $2.33 M(+79.6%) |
| Dec 2011 | $1.30 M(+24.8%) | $1.30 M(+32.0%) |
| Sept 2011 | - | $985.00 K(-3.2%) |
| June 2011 | - | $1.02 M(-36.3%) |
| Mar 2011 | - | $1.60 M(+53.4%) |
| Dec 2010 | $1.04 M(-97.8%) | $1.04 M(-43.8%) |
| Sept 2010 | - | $1.85 M(-54.1%) |
| June 2010 | - | $4.03 M(-30.0%) |
| Mar 2010 | - | $5.76 M(-87.6%) |
| Dec 2009 | $46.60 M(-3.6%) | $46.60 M(+2.4%) |
| Sept 2009 | - | $45.52 M(-2.1%) |
| June 2009 | - | $46.50 M(-2.7%) |
| Mar 2009 | - | $47.80 M(-1.2%) |
| Dec 2008 | $48.35 M(-21.6%) | $48.35 M(-22.7%) |
| Sept 2008 | - | $62.54 M(-1.0%) |
| June 2008 | - | $63.15 M(-0.9%) |
| Mar 2008 | - | $63.76 M(+3.3%) |
| Dec 2007 | $61.70 M(+2372.8%) | $61.70 M(-0.6%) |
| Sept 2007 | - | $62.06 M(-0.6%) |
| June 2007 | - | $62.40 M(-0.3%) |
| Mar 2007 | - | $62.56 M(+2407.5%) |
| Dec 2006 | $2.50 M(+939.2%) | $2.50 M(-4.9%) |
| Sept 2006 | - | $2.62 M(+55.1%) |
| June 2006 | - | $1.69 M(+609.9%) |
| Mar 2006 | - | $238.20 K(-0.8%) |
| Dec 2005 | $240.10 K(-99.7%) | $240.10 K(-0.8%) |
| Sept 2005 | - | $242.00 K(+64.7%) |
| June 2005 | - | $146.90 K(-99.8%) |
| Mar 2005 | - | $77.21 M |
| Dec 2004 | $77.10 M(+47.2%) | - |
| Dec 2003 | $52.38 M(+208.3%) | - |
| Dec 2001 | $16.99 M | - |
FAQ
- What is DexCom annual total long term liabilities?
- What is the all time high annual total long term liabilities for DexCom?
- What is DexCom annual total long term liabilities year-on-year change?
- What is DexCom quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for DexCom?
- What is DexCom quarterly long term liabilities year-on-year change?
What is DexCom annual total long term liabilities?
The current annual total long term liabilities of DXCM is $2.64 B
What is the all time high annual total long term liabilities for DexCom?
DexCom all-time high annual total long term liabilities is $2.64 B
What is DexCom annual total long term liabilities year-on-year change?
Over the past year, DXCM annual total long term liabilities has changed by +$1.22 B (+85.83%)
What is DexCom quarterly total long term liabilities?
The current quarterly long term liabilities of DXCM is $2.64 B
What is the all time high quarterly long term liabilities for DexCom?
DexCom all-time high quarterly total long term liabilities is $2.65 B
What is DexCom quarterly long term liabilities year-on-year change?
Over the past year, DXCM quarterly total long term liabilities has changed by -$9.40 M (-0.35%)